RenovoRx, Inc. (RNXT)
0.849
-0.01
(-1.69%)
USD |
NASDAQ |
May 11, 16:00
RenovoRx EPS Diluted (Quarterly) : -0.0803 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -1.671 |
| BioRestorative Therapies, Inc. | -0.3614 |
| CytomX Therapeutics, Inc. | -0.1029 |
| Tenaya Therapeutics, Inc. | -0.0889 |
| Prime Medicine, Inc. | -0.2774 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.941M |
| Revenue (Quarterly) | 0.238M |
| Total Expenses (Quarterly) | 3.179M |
| Enterprise Value | 32.10M |
| Gross Profit Margin (Quarterly) | 88.24% |
| Profit Margin (Quarterly) | -1.24K% |
| Earnings Yield | -37.23% |
| Normalized Earnings Yield | -39.49 |